Curis (CRIS) Posts Q3 Loss of $0.06, In-Line with Estimates
More News related to CRIS
- Curis to Present at Piper Jaffray 21st Annual Healthcare Conference
- ThinkEquity Initiates Coverage on Curis (CRIS) with a Buy
- Curis to Present at Lazard Capital Markets 6th Annual Healthcare Conference
- Curis to Present at Merriman Curhan Ford's Investor Summit 2009
- Curis (CRIS) Posts Q3 Loss of $0.06, In-Line with Estimates
More News related to Earnings
- Hoku Scientific (HOKU) Amends Poly Deal with Jinko Solar
- American International Group (AIG), Greenberg and Smith Settle Disputes
- Heska (HSKA) Announces Agreements with Roche for Blood Gas Product Supply/Affiliated Consumables
- AIG, Greenberg and Smith to settle all disputes
- DryShips (DRYS) Announces Exercise of Over-Allotment Option by Underwriters, Closes Convertible Senior Notes Offering for Net Proceeds of $448M
Curis (NASDAQ: CRIS) reports Q3 loss of $0.06, even with the analyst estimate of ($0.06). Revenue for the quarter was $763,000, which compares to the estimate of $901,000.
Related Categories
EarningsStocks Mentioned
-0.04Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
